Administration of cephalothin to normal volunteers in maximal doses of 300 mg/kg per day resulted in a combined defect of platelet function and blood coagulation. No such abnormalities were evident after infusion of cefazolin or cephapirin at a maximal dosage of 200 mg/kg per day. The observed thrombocytopathy was similar to but less severe than that induced by carbenicillin or ticarcillin and was not reflected by a prolonged bleeding time test or impaired prothrombin consumption. Moreover, it was not a consistent finding in those persons receiving cephalothin. A separate defect involving blood coagulation appeared to result from delayed fibrinogen-fibrin polymerization and was evidenced by extended values of the activated partial thromboplastin and thrombin time tests. It remains uncertain whether the abnormalities described may constitute clinically important hemostatic disorders in patients with normal renal function receiving large doses of cephalosporin antibiotics.
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Recent studies have confirmed that a specific hemostatic defect may be induced by administration of certain penicillin derivatives (2, 3) . Cephalosporins are closely related in chemical structure to penicillin and have also been implicated as causative of coagulation abnormalities (6) . To further investigate this phenomenon, we have studied the effect of three cephalosporin compounds on blood coagulation and platelet function in 15 normal volunteers.
The specific drugs chosen for this study, in addition to cephalothin (Keflin), were two new semisynthetic cephalosporin antibiotics, cefazolin (Kefzol) and cephapirin (Cephadyl). These products appear equivalent in antibacterial spectrum to cephalothin but afford greater and more prolonged serum levels after parenteral injection of an identical dose. They may also offer a lower incidence of thrombophlebitis when given by intravenous injection (1, 4 urements of plasma fibrinogen concentration were performed both by measuring the rate of change in optical density (V,,JJ,AOD) of clotting plasma (7, 8) and by biuret digestion of a fibrin clot.
RESULTS
Five subjects received cephalothin, but in one the study terminated prematurely (day 6) because of difficulty in maintaining an infusion through unsuitable peripheral veins. Another manifested clinical evidence of mild phlebitis (day 9), and we discontinued the drug. None of the subjects experienced a bleeding tendency while under observation.
During the period of cephalothin administration, all tests of blood coagulation and platelet function remained normal and unchanged from base-line values with the exception of platelet aggregation, PT, APTT, TT, and estimation of plasma fibrinogen concentration by the photometric method. Three of the five volunteers demonstrated loss of the second wave of aggregation in response to epinephrine and reduced total aggregation to an ADP stimulus (Fig. 1 ). When present, these abnormalities were evident by day 3; they disappeared 6 to 9 days after discontinuation of drug.
In two subjects all aggregation responses remained entirely normal.
All three subjects receiving cephalothin for at least 10 days manifested prolongation of TT (up to 3 s) and APTT (up to 25 s) above base-line ANTIMICROB. AGENTS CHEMOTHER. values (Fig. 2) . In these subjects the rapidly clottable fibrinogen concentration as measured by maximal optical density changes (VmaxAOD) in the TT test became 50 to 115 mg/100 ml lower than total plasma fibrinogen (biuret), suggesting an alteration in the initial rate of fibrinogen-fibrin polymerization (7, 8) .
All five subjects who received cefazolin tolerated the drug without incident and none experienced phlebitis. In this group all tests of platelet function and blood coagulation remained normal and unchanged from base-line values throughout the study period.
Among the five subjects given cephapirin, one experienced an allergic reaction at day 7 consisting of fever and urticarial rash, and he received no further drug. None of the remaining group evidenced an untoward reaction. Tests of hemostasis and platelet function remained normal in all five subjects during drug infusion. 
DISCUSSION
The pathogenesis and clinical significance of the abnormality in platelet function described here after infusion of cephalothin into normal volunteers remain uncertain. The pattern of defective platelet aggregation is similar to that induced by semisynthetic penicillins and comprises loss of the secondary wave in response to an epinephrine or ADP stimulus. With both classes of antibiotic, continued presence of the defect long after cessation of drug suggests a permanent alteration in platelet membrane receptors (2, 3) . Unlike the carbenicillin-and ticarcillin-induced thrombocytopathy, however, we did not observe changes in bleeding time, prothrombin consumption, or clot retraction after cephalothin. Moreover, abnormalities in platelet function were not present in all subjects receiving cephalothin and were not evident in those given cefazolin or cephapirin.
An unexpected finding in three volunteers receiving cephalothin was prolongation of the APTT and TT. Reduced maximal rate of change in optical density (V,,AOD) during plasma coagulation in both these tests and the PT (Fig. 2) suggested retarded fibrinogenfibrin polymerization (7, 8) . A similar process has been described in vitro in the presence of large concentrations of penicillin (5) but was not present in vivo in normal subjects after sustained intensive treatment with carbenicillin or ticarcillin (2, 3). Although we did not observe any change in plasma coagulation in those subjects given cefazolin or cephapirin, presence of this defect may be dose related. Such a coagulopathy has been reported in a patient with renal failure who received cefazolin and achieved massive blood levels of the drug (6).
Our findings suggest that patients with normal renal function are unlikely to manifest clinically important hemostatic abnormalities consequent to cephalosporins alone, even when given in maximally recommended dosage.
Certainly in patients with compromised renal function and those in whom the antibiotic is used in combination with carbenicillin or ticarcillin careful attention should be given to the dosage regimen to avoid the potential hazard of a bleeding diathesis (2, 4) .
